Vertex Pharmaceuticals (VRTX)

423.92
-3.46 (-0.81%)
NASDAQ · Last Trade: May 2nd, 12:42 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Set It and Forget It: 3 Monster Stocks Worth Holding Through Whatever Comes Nextfool.com
They may suffer the occasional knee-jerk setback. By and large, though, investors understand these companies are capable of standing up to almost any challenge.
Via The Motley Fool · May 1, 2026
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Consideringfool.com
These companies are leaders in their fields.
Via The Motley Fool · April 30, 2026
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.fool.com
The biotech's candidate may treat a great number of illnesses that have one thing in common.
Via The Motley Fool · April 30, 2026
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Stock with Promising Technical Setupchartmill.com
Via Chartmill · April 29, 2026
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Growth and Technical Setupchartmill.com
Via Chartmill · April 3, 2026
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investmentchartmill.com
Via Chartmill · March 28, 2026
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?fool.com
This particular player has seen its yield rise in recent years.
Via The Motley Fool · April 30, 2026
3 Growth Stocks That Could Generate 10X Returnsfool.com
These stocks come with risk, but they also have some exciting long-term growth opportunities.
Via The Motley Fool · April 29, 2026
3 of Wall Street’s Favorite Stocks Worth Your Attention
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · April 29, 2026
3 Market-Beating Stocks to Consider Right Now
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...
Via StockStory · April 28, 2026
3 Healthcare Stocks With the Most Durable Competitive Moatsfool.com
These companies offer a clear path to sustained earnings growth.
Via The Motley Fool · April 23, 2026
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?fool.com
We'll know more about the company's medium-term prospects by the end of the year.
Via The Motley Fool · April 21, 2026
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Termfool.com
Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
Via The Motley Fool · April 19, 2026
Is Vertex Pharmaceuticals' Empire in Trouble?fool.com
It might not be too late to invest in this company.
Via The Motley Fool · April 16, 2026
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Via StockStory · April 16, 2026
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.fool.com
Could the White House be overly optimistic about inflation? If so, you may want to own these stocks.
Via The Motley Fool · April 14, 2026
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?fool.com
With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has attracted a big Investor.
Via The Motley Fool · April 7, 2026
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have ou...
Via StockStory · April 2, 2026
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
In a trading session characterized by sharp declines across the technology and industrial sectors, the healthcare industry emerged as a resilient fortress on March 31, 2026. While the broader S&P 500 and Nasdaq Composite indices tumbled over 1.5% due to lingering inflation concerns and a surprise hawkish pivot
Via MarketMinute · March 31, 2026
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · March 30, 2026
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anywayfool.com
Some stocks can zig when the overall market zags.
Via The Motley Fool · March 28, 2026
2 Stocks I Plan to Hold for the Next 20 Yearsfool.com
These companies help me sleep peacefully at night.
Via The Motley Fool · March 27, 2026
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Via StockStory · March 27, 2026
Where Will Vertex Pharmaceuticals Be in 1 Year?fool.com
The biotech's recent dip might be a buying opportunity.
Via The Motley Fool · March 25, 2026
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?fool.com
The gene-editing stock has been in a tailspin of late.
Via The Motley Fool · March 23, 2026